In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on escherichia coli

Research in Pharmaceutical Sciences

Volumn 8, Issue 4, 2013, Pages 261-268

  Abedi, D ^a   Feizizadeh, S ^a   Akbari, V ^a   Jafarin Dehkordi, A ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti adherence; Anti bacterial; Escherichia coli; Lactobacillus delbrueckii

Indexed keywords

PROBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CELL STRAIN CACO 2; COMPETITIVE INHIBITION; DISK DIFFUSION; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS BULGARICUS; NONHUMAN;

EID: 84873348696     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Curry B, Crow V. Lactobacillus spp.: General characteristics. Encyclopedia of Dairy Science ed. Roginski, H., Funquay, J. and Fox, P. 2003:1479- 1511.
2. Guarner F, Perdigon G, Corthier G, Salminen S, Koletzko B, Morelli L. Should yoghurt cultures be considered probiotic? Brit J Nutr. 2005;93:783-786. (Pubitemid 43899554)
3. Guglielmotti DM, Marcó MB, Golowczyc M, Reinheimer JA, Quiberoni AL. Probiotic potential of Lactobacillus delbrueckii strains and their phage resistant mutants. Int Dairy J. 2007;17:916-925. (Pubitemid 46566503)
4. Oelschlaeger TA. Mechanisms of probiotic actions- A review. Int J Med Microbiol. 2010;300:57-62.
5. Collado M, Grze kowiak, Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol. 2007;55:260-265. (Pubitemid 47237946)
6. Banerjee P, Merkel G, Bhunia A. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog. 2009;1:8-19.
7. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130:396S-402S. (Pubitemid 30073758)
8. Kelly CG, Younson JS. Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces. Expert Opin Inv Drug. 2000;9:1711-1721. (Pubitemid 30639322)
9. Scheld WM, Zak O, Vosbeck K, Sande M. Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clinl Invest. 1981;68:1381-1384. (Pubitemid 12235043)
10. Fauci AS, Morens DM. The perpetual challenge of infectious diseases. New Engl J Med. 2012;366:454- 461.
11. Venugopal AA, Johnson S. Fidaxomicin: A novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. Clin Infect Dis. 2012;54:568-574.
12. Bernet M, Brassart D, Neeser J, Servin A. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 1994;35:483-489. (Pubitemid 24131244)
13. Collado M, Meriluoto J, Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol. 2007;45:454-460. (Pubitemid 47493153)
14. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2009;8:26-38.
15. Tufail M, Hussain S, Malik F, Mirza T, Parveen G, Shafaat S, et al. Isolation and evaluation of antibacterial activity of bacteriocin produced by Lactobacillus bulgaricus from yogurt. Afr J Microbiol Res. 2011;5:3842-3847.
16. Šušković J, Kos B, Beganović J, Leboš Pavunc A, Habjanič K, Matošić S. Antimicrobial activity-The most important property of probiotic and starter lactic acid bacteria. Food Technol Biotechnol. 2010;48:296-307.
17. De Keersmaecker SCJ, Verhoeven TLA, Desair J, Marchal K, Vanderleyden J, Nagy I. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol Lett. 2006;259:89-96.
18. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biolo Toxicol. 2005;21:1-26. (Pubitemid 40767684)
19. Vesterlund S, Karp M, Salminen S, Ouwehand AC. Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiol. 2006;152:1819-1826.
20. Lee YK, Puong KY, Ouwehand AC, Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol. 2003;52:925-930. (Pubitemid 37297325)
21. Lee Y, Puong K. Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Brit J Nutr. 2002;88:101-108.
22. Matijašić BB, Stojković S, Salobir J, Malovrh Š, Rogelj I. Evaluation of the Lactobacillus gasseri K7 and LF221 strains in weaned piglets for their possible probiotic use and their detection in the feces. Anim Res. 2004;53:35-44. (Pubitemid 38285564)
23. Lee Y, Lim C, Teng W, Ouwehand A, Tuomola E, Salminen S. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol. 2000;66:3692-3697.
24. Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser J, et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut. 2000;47:646-652.
25. Biasco G, Paganelli G, Brandi G, Brillanti S, Lami F, Callegari C, et al. Effect of lactobacillus acidophilus and bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital J gastroenterol. 1991;23:142.
26. Romond MB, Ais A, Guillemot F, Bounouader R, Cortot A, Romond C. Cell-free whey from milk fermented with Bifidobacterium breve C50 used to modify the colonic microflora of healthy subjects. J Dairy Sci. 1998;81:1229-1235. (Pubitemid 128448494)